These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36824969)

  • 1. Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.
    Srivastava R; Labani-Motlagh A; Chen A; Yang F; Ansari D; Patel S; Ji H; Trasti S; Dodda M; Patel Y; Zou H; Hu B; Yi G
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.
    Srivastava R; Labani-Motlagh A; Chen A; Bohorquez JA; Qin B; Dodda M; Yang F; Ansari D; Patel S; Ji H; Trasti S; Chao Y; Patel Y; Zou H; Hu B; Yi G
    Antib Ther; 2023 Oct; 6(4):253-264. PubMed ID: 38075240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination immunotherapy strategies for glioblastoma.
    Chan HY; Choi J; Jackson C; Lim M
    J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-cohort humanized NPI mice reconstituted with CD34
    Xu X; Gu H; Li H; Gao S; Shi X; Shen J; Li B; Wang H; Zheng K; Shao Z; Cheng P; Cha Z; Peng S; Nie Y; Li Z; Guo S; Qian B; Jin G
    FASEB J; 2022 Apr; 36(4):e22244. PubMed ID: 35262964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice.
    Liu L; van Schaik TA; Chen KS; Rossignoli F; Borges P; Vrbanac V; Wakimoto H; Shah K
    Front Immunol; 2023; 14():1324618. PubMed ID: 38274817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
    Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
    Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized HLA-DR4.RagKO.IL2RγcKO.NOD (DRAG) mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria.
    Wijayalath W; Majji S; Villasante EF; Brumeanu TD; Richie TL; Casares S
    Malar J; 2014 Sep; 13():386. PubMed ID: 25266106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
    Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
    J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized PD-1 Knock-in Mice Reveal Nivolumab's Inhibitory Effects on Glioblastoma Tumor Progression
    Chiang CY; Huang MC; Tsai SC; Hsu FT; Liao TL; Yu JH; Lin TH; Huang HH; Liao PA
    In Vivo; 2023; 37(5):1991-2000. PubMed ID: 37652472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.
    Wu A; Maxwell R; Xia Y; Cardarelli P; Oyasu M; Belcaid Z; Kim E; Hung A; Luksik AS; Garzon-Muvdi T; Jackson CM; Mathios D; Theodros D; Cogswell J; Brem H; Pardoll DM; Lim M
    J Neurooncol; 2019 Jun; 143(2):241-249. PubMed ID: 31025274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
    Medikonda R; Choi J; Pant A; Saleh L; Routkevitch D; Tong L; Belcaid Z; Kim YH; Jackson CM; Jackson C; Mathios D; Xia Y; Shah PP; Patel K; Kim T; Srivastava S; Huq S; Ehresman J; Pennington Z; Tyler B; Brem H; Lim M
    J Neurosurg; 2022 Feb; 136(2):379-388. PubMed ID: 34388730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
    Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells.
    Danner R; Chaudhari SN; Rosenberger J; Surls J; Richie TL; Brumeanu TD; Casares S
    PLoS One; 2011; 6(5):e19826. PubMed ID: 21611197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma.
    Wouters R; Bevers S; Riva M; De Smet F; Coosemans A
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [
    Nagle VL; Henry KE; Hertz CAJ; Graham MS; Campos C; Parada LF; Pandit-Taskar N; Schietinger A; Mellinghoff IK; Lewis JS
    Clin Cancer Res; 2021 Apr; 27(7):1958-1966. PubMed ID: 33495310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV
    Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ
    J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.